STOCKHOLM – May 27, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced the release of RiventTM, its seventh generation of image enhancement software for 2D ultrasound.
Fredrik Palm, CEO of ContextVision, has on May 19, 2020 purchased 120 shares in ContextVision AB at an average price of NOK 155 per share. After the transaction, Mr Palm holds a total of 2620 shares in ContextVision AB.
ContextVision today announced the strengthening of its board of directors. Martin Ingvar, Professor of Integrative Medicine at Karolinska Institute Sweden and founding member of International Consortium for Health Outcome Measurements (ICHOM), was elected as new member of the board at the annual general meeting.
On the 6th of May 2020, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm. The annual financial report regarding 2019 was presented and approved by the AGM. Disposition of financial results according to the proposal of the Board of Directors was approved. The Managing Director and the Board of Directors were discharged from […]
Stockholm, May 6, 2020 The ContextVision AB:s Profit Sharing Foundation has sold and purchased shares in ContextVision AB in accordance with the rules related to the foundation. The ContextVision AB:s Profit Sharing Foundation has sold 30,500 shares on April 28, at an average price of 120 NOK/share, in accordance with the rules related to the […]